Legal access to psychedelic medicine, including psilocybin (magic mushrooms) and MDMA, for treating mental health disorders like PTSD and TRD, is now permitted in Australia. Access remains limited, requiring patients to navigate a complex and costly programs for around $20,000.
Australia remains ahead in legalising psychedelic-assisted therapy, as the FDA rejects Lykos’ MDMA for PTSD treatment.
Three patients are the first in NSW to receive MDMA as part of psychedelic-assisted therapy. The lead director of the program, Professor Ranil Gunewardene, is the only authorised prescriber in the state.
Free, voluntary and confidential pill testing for Schoolies, and what to expect from the service.
Southern Cross University researchers will run stepped care treatment clinical trial, including psychedelic-assisted therapy, for Lismore flood victims with PTSD
Pill testing available at Victorian music festivals this summer and at a fixed site near Melbourne city centre from 2025.